Do nootropic drugs create an uneven playing field?
Whilst the use of cognitive enhancers clearly would provide
some extra comparative benefit to a person, it does
so in the background of a plethora of inequalities (economic,
social, genetic, environmental) which can contribute
to inequalities in cognitive function. Secondly,
given that such substances are already being used (fairly
widely) for their nootropic effects, the playing field is
already tipped towards those who can afford them. By
providing them under legal prescription, we aim to remove
economic and legal barriers to their access.